Feasibility of photoacoustic evaluations on dual-thermal treatment of ex vivo bladder tumors

Van Phuc Nguyen, Junghwan Oh, Suhyun Park, Hyun Wook Kang

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

A variety of thermal therapeutic methods have been investigated to treat bladder tumors but often cause bowel injury and bladder wall perforation due to high treatment dosage and limited clinical margins. The objective of the current study is to develop a dual-thermal modality to deeply coagulate the bladder tumors at low thermal dosage and to evaluate therapeutic outcomes with high contrast photoacoustic imaging (PAI). High intensity focused ultrasound (HIFU) is combined with 532 nm laser light to enhance therapeutic depth during thermal treatments on artificial tumor-injected bladder tissue ex vivo. PAI is employed to identify the margins of the tumors pre- and post-treatments. The dual-thermal modality achieves 3- and 1.8-fold higher transient temperature changes and 2.2- and 1.5-fold deeper tissue denaturation than laser and HIFU, respectively. PAI vividly identifies the position of the injected tumor and entails approximately 7.9 times higher image contrast from the coagulated tumor as that from the untreated tumor. Spectroscopic analysis exhibits that both 740 nm and 760 nm attains the maximum photoacoustic amplitudes from the treated areas. The proposed PAI-guided dual-thermal treatments (laser and HIFU) treatments can be a feasible therapeutic modality to treat bladder tumors in a controlled and efficient manner. (Figure presented.).

Original languageEnglish
Pages (from-to)577-588
Number of pages12
JournalJournal of Biophotonics
Volume10
Issue number4
DOIs
StatePublished - 1 Apr 2017

Keywords

  • Bladder tumors
  • dual-thermal treatments
  • HIFU
  • laser treatments
  • photoacoustic imaging

Fingerprint

Dive into the research topics of 'Feasibility of photoacoustic evaluations on dual-thermal treatment of ex vivo bladder tumors'. Together they form a unique fingerprint.

Cite this